Dr Pepper Snapple Group, Inc (DPS) Receives Consensus Rating of “Hold” from Analysts

Dr Pepper Snapple Group, Inc (NYSE:DPS) has received a consensus rating of “Hold” from the sixteen ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $99.25.

DPS has been the topic of several research analyst reports. Jefferies Group LLC restated a “buy” rating and set a $112.00 target price on shares of Dr Pepper Snapple Group in a report on Friday, June 23rd. Zacks Investment Research upgraded Dr Pepper Snapple Group from a “hold” rating to a “buy” rating and set a $104.00 price target on the stock in a report on Tuesday, June 27th. UBS AG raised their price target on Dr Pepper Snapple Group from $98.00 to $99.00 and gave the company a “neutral” rating in a report on Friday, July 28th. Credit Suisse Group reiterated a “buy” rating on shares of Dr Pepper Snapple Group in a report on Friday, June 23rd. Finally, BMO Capital Markets upgraded Dr Pepper Snapple Group from a “market perform” rating to an “outperform” rating and raised their price target for the company from $98.00 to $105.00 in a report on Wednesday, June 7th. They noted that the move was a valuation call.

ILLEGAL ACTIVITY WARNING: “Dr Pepper Snapple Group, Inc (DPS) Receives Consensus Rating of “Hold” from Analysts” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://stocknewstimes.com/2017/09/30/dr-pepper-snapple-group-inc-dps-receives-consensus-rating-of-hold-from-analysts.html.

In other Dr Pepper Snapple Group news, insider Angela A. Stephens sold 7,700 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $91.12, for a total transaction of $701,624.00. Following the completion of the sale, the insider now directly owns 6,053 shares in the company, valued at approximately $551,549.36. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Angela A. Stephens sold 3,160 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $92.51, for a total transaction of $292,331.60. Following the sale, the insider now owns 16,913 shares of the company’s stock, valued at $1,564,621.63. The disclosure for this sale can be found here. 0.58% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Chilton Investment Co. LLC purchased a new stake in Dr Pepper Snapple Group during the 2nd quarter valued at $21,943,000. Principal Financial Group Inc. raised its stake in Dr Pepper Snapple Group by 195.9% during the 2nd quarter. Principal Financial Group Inc. now owns 1,209,566 shares of the company’s stock valued at $110,203,000 after buying an additional 800,808 shares during the last quarter. AJO LP raised its stake in Dr Pepper Snapple Group by 57.0% during the 2nd quarter. AJO LP now owns 864,974 shares of the company’s stock valued at $78,808,000 after buying an additional 314,125 shares during the last quarter. Wells Fargo & Company MN raised its stake in Dr Pepper Snapple Group by 0.7% during the 2nd quarter. Wells Fargo & Company MN now owns 2,259,175 shares of the company’s stock valued at $205,835,000 after buying an additional 15,523 shares during the last quarter. Finally, Global Financial Private Capital LLC purchased a new stake in Dr Pepper Snapple Group during the 1st quarter valued at $1,708,000. Institutional investors and hedge funds own 89.98% of the company’s stock.

Dr Pepper Snapple Group (DPS) traded up 0.12% during midday trading on Friday, reaching $88.47. 1,429,005 shares of the company traded hands. Dr Pepper Snapple Group has a 12-month low of $81.05 and a 12-month high of $99.47. The company has a 50-day moving average price of $91.26 and a 200-day moving average price of $92.90. The company has a market cap of $16.08 billion, a price-to-earnings ratio of 21.22 and a beta of 0.61.

Dr Pepper Snapple Group (NYSE:DPS) last announced its earnings results on Thursday, July 27th. The company reported $1.25 EPS for the quarter, missing the consensus estimate of $1.28 by ($0.03). The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.77 billion. Dr Pepper Snapple Group had a return on equity of 38.28% and a net margin of 11.73%. Dr Pepper Snapple Group’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.25 EPS. On average, analysts predict that Dr Pepper Snapple Group will post $4.60 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 5th. Investors of record on Thursday, September 14th will be issued a $0.58 dividend. The ex-dividend date is Wednesday, September 13th. This represents a $2.32 dividend on an annualized basis and a yield of 2.62%. Dr Pepper Snapple Group’s payout ratio is currently 55.64%.

About Dr Pepper Snapple Group

Dr Pepper Snapple Group, Inc is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The Company offers a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

Analyst Recommendations for Dr Pepper Snapple Group (NYSE:DPS)

Receive News & Ratings for Dr Pepper Snapple Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply